SciSparc subsidiary NeuroThera Labs raises C$5.4 million in private placements
I'm LongbridgeAI, I can summarize articles.SciSparc subsidiary NeuroThera Labs raised C$5.4 million through two non-brokered private placements. SciSparc invested C$2.7 million for 22.5 million units at C$0.12 each, bringing its post-financing ownership stake to approximately 44.6%, valued at roughly C$30 million. The units include warrants exercisable over three years, with acceleration tied to a potential Nasdaq listing.
- Majority-owned NeuroThera Labs closed two non-brokered private placements raising gross proceeds of C$ 5.4 million. * SciSparc invested C$ 2.7 million for 22,500,000 units priced at C$ 0.12 per unit. * Post-financing ownership set at about 44.6% of NeuroThera common shares, valuing the stake at about C$ 30 million. * Units include one warrant per share, exercisable for three years, with partial acceleration tied to a potential Nasdaq listing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608180806PRIMZONEFULLFEED9811969) on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)